Table 5.
Mediation of proteins on the association between RDW and all-cause mortality in adults without medical conditions (sorted by p-values in indirect association).
Mediator |
Total association of RDW with all-cause mortality |
Direct association of RDW with all-cause mortality |
Indirect association of RDW with all-cause mortality through mediator |
Proportion mediated | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rank | Target | EntrezGene Symbol |
β | 95%CI | p-value | β | 95%CI | p-value | β | 95%CI | p-value | ||||
Cross-sectional analysis† | |||||||||||||||
1 | TrkB | NTRK2 | 0.85 | 0.76 | 0.96 | 0.01 | 0.89 | 0.79 | 1.005 | 0.06 | 0.96 | 0.93 | 0.99 | 0.01 | 54.5% |
2 | KLRF1 | KLRF1 | 0.86 | 0.76 | 0.96 | 0.01 | 0.88 | 0.78 | 0.997 | 0.04 | 0.97 | 0.95 | 0.99 | 0.02 | 51.7% |
3 | ERBB1 | EGFR | 0.87 | 0.77 | 0.98 | 0.02 | 0.89 | 0.79 | 1.01 | 0.06 | 0.97 | 0.94 | 0.99 | 0.02 | 53.3% |
4 | TrkC | NTRK3 | 0.86 | 0.77 | 0.97 | 0.02 | 0.89 | 0.79 | 1.003 | 0.06 | 0.97 | 0.95 | 0.996 | 0.02 | 52.3% |
5 | Growth hormone receptor | GHR | 0.85 | 0.75 | 0.96 | 0.01 | 0.88 | 0.78 | 0.99 | 0.04 | 0.96 | 0.93 | 0.996 | 0.03 | 52.7% |
6 | LRP1B | LRP1B | 0.87 | 0.77 | 0.99 | 0.03 | 0.89 | 0.79 | 1.01 | 0.07 | 0.98 | 0.96 | 0.999 | 0.04 | 51.6% |
7 | IGFBP-2 | IGFBP2 | 0.87 | 0.77 | 0.98 | 0.02 | 0.88 | 0.78 | 0.99 | 0.04 | 0.99 | 0.97 | 0.9998 | 0.05 | 49.3% |
Longitudinal analysis‡ | |||||||||||||||
1 | TFF3 | TFF3 | 0.36 | 0.08 | 1.66 | 0.19 | 0.55 | 0.11 | 2.78 | 0.47 | 0.66 | 0.44 | 0.98 | 0.04 | 43.9% |
2 | IGFBP-2 | IGFBP2 | 0.31 | 0.06 | 1.52 | 0.15 | 0.42 | 0.08 | 2.09 | 0.29 | 0.74 | 0.55 | 0.99 | 0.04 | 33.0% |
Protein-specific accelerated failure time model with exponetial estimation. RDW-mediator (one protein) associations were modeled with multivariable linear regression model. All models were adjusted for age, sex, body mass index, smoking status (current smoker or not), education level (6-year education or higher education or not), and haemoglobin.
RDW and proteins were measured at baseline. Outcome was 15-year all-cause mortality.
Longitudinal changes in RDW and proteins were calculated from {(9-year follow-up visit - baseline visit)/exact time intervals in each participant}. Outcome was 6-year all-cause mortality from 9-year follow-up visit.